Skip to main content
Press ⌘K to search

Capital, executives & screening

Cover capital-return programs, executive changes and pay, the stock screener, federal contract awards, and scheduled FDA advisory-committee catalysts. Figures come from SEC filings, USAspending, and the FDA's own calendar; nothing is estimated.

GetBuybackPrograms

A company's share-repurchase picture — tracked programs (authorized total, remaining, expiry), the latest authorization, and the repurchase history (cash spent, shares, average price) by fiscal year — from XBRL facts plus verified extractions of the filings' narrative. Nothing is estimated.

Parameters: ticker (required).

Ask: "How much stock has NVIDIA been buying back?"

Returns (trimmed):

# Share repurchases — NVDA (Nvidia Corp)

## Tracked programs

| Announced  | Authorized      | Remaining       | As of      | Source           |
|------------|----------------:|----------------:|------------|------------------|
| 2026-05-18 | $80,000,000,000 | $38,500,000,000 | 2026-04-26 | 8-K, 2026-05-20  |

## Repurchase history (fiscal years)

| Fiscal year ended | Cash spent      | Shares      | Source            |
|-------------------|----------------:|------------:|-------------------|
| 2026-01-25        | $40,086,000,000 | 282,000,000 | 10-K, 2026-02-25  |

GetAtmPrograms

At-the-market (ATM) equity programs — executed sales/distribution agreements under which a company sells new shares directly into the market. Returns the original agreement date at its filed precision, latest amendment, money and/or share capacity, cumulative sales, remaining availability with per-figure dates, and source filing. Bare table figures are normalized only from an exact filing scale header; nothing is estimated. Coverage is rolling out, so an empty result states the scanned scope rather than claiming no program exists.

Parameters: ticker (required).

Ask: "What has BNGO sold through its at-the-market program?"

Returns:

# At-the-market (ATM) equity offering programs — BNGO (Bionano Genomics, Inc.)

From verified extractions of the company's filings — offering-note prose and disclosure tables; ATM programs have no tagged XBRL equivalent. A dash means the filings never stated the figure; nothing is estimated. Status only compares the company's own reported figures and dates (sold vs. capacity, the run-through date vs. today).

| Established | Last amended | Capacity | Sold | Remaining | Runs through | Status | Source |
|---|---|---:|---:|---:|---|---|---|
| 2025-02-21 | — | $75,000,000 | $1,300,000 as of 2026-06-30 | — | — | — | [10-Q filed 2026-08-10](https://www.sec.gov/Archives/edgar/data/0001411690/0001411690-26-000044.txt) |

GetExecutiveChanges

Executive and director appointments and departures, extracted from Item-5.02 8-K filings — each with the person, role text exactly as filed, a separate normalized role classification, the nature of the change, its effective date, the verbatim disclosure, and a link to the source 8-K. The output names the queried company's own coverage — how many of ITS 8-Ks the lane has read and the filed-date span they cover (the lane drains newest-first and is still back-filling history) — and an empty answer distinguishes "covered filings disclose no changes" from "filings not yet processed."

Parameters: ticker (required), maxResults, offset (default 0), action (Appointed / Resigned / Terminated / Retired), startDate / endDate (filed-date window, YYYY-MM-DD).

Ask: "Any recent executive changes at NVIDIA?"

Returns (trimmed):

# Executive changes — NVDA (Nvidia Corp)

| Filed | Person | Role as filed | Normalized role | Change | Effective | Disclosure | Source |
|-------|--------|---------------|-----------------|--------|-----------|------------|--------|
| 2026-07-02 | Nicholas Parker | Executive Vice President, Worldwide Field Ops | Officer | Appointed | 2026-08-24 | appointed Nicholas Parker as Executive Vice President… | [8-K](https://www.sec.gov/…) |

Coverage: extracted from NVDA's 11 covered 8-K filing(s), filed 2023-03-08 to 2026-07-02 — the lane reads newest filings first and is still back-filling older history.

GetExecutiveCompensation

Named-executive pay from the company's DEF 14A Summary Compensation Table — salary, bonus, stock and option awards, non-equity incentive, other, and the company-reported total, per fiscal year. Amounts are nominal USD exactly as disclosed. Coverage is limited to US DEF 14A filers (foreign private issuers file 20-F and are not covered) and is still back-filling: the header states the newest imported fiscal year next to the newest proxy on file, so stale coverage is self-describing.

Parameters: ticker (required), maxYears (default 0 = all imported years).

Ask: "What does NVIDIA pay its top executives?"

Returns (trimmed to fiscal 2022):

# Executive compensation — NVDA (Nvidia Corp)

Newest fiscal year imported: FY2022. Newest DEF 14A on file: filed 2026-05-12 — years disclosed in proxies not yet imported may be missing.

## Fiscal 2022

| Executive       | Role          | Salary   | Stock awards | Non-equity incentive | Total       |
|-----------------|---------------|---------:|-------------:|---------------------:|------------:|
| Jen-Hsun Huang  | CEO           | $996,216 |  $18,660,407 |           $4,000,000 | $23,737,661 |
| Colette Kress   | CFO           | $896,595 |   $8,269,020 |             $600,000 |  $9,775,927 |

ScreenStocks

Screen US listings, or European, Chinese and Hong Kong listings with market, by combining range filters across datasets — market cap, price, sector, industry, 13F filer count and its quarter-over-quarter change, short interest %, days to cover, the composite squeeze and insider-sentiment scores, net insider buying, and the going-concern flag. Every bound is optional, and each returned row names its sector and industry taxonomy.

Parameters: all optional.

Range filter Minimum Maximum Basis
Market cap minMarketCap maxMarketCap Market value
Price minPrice maxPrice Stock price
13F filers minFilerCount maxFilerCount Filer count
Filer change minFilerDelta maxFilerDelta Quarter-over-quarter change
Short interest minShortInterestPercent maxShortInterestPercent Percent
Days to cover minDaysToCover maxDaysToCover Days
Squeeze score minSqueezeScore maxSqueezeScore Composite score
Insider sentiment minInsiderSentiment maxInsiderSentiment Composite score
Net insider buying minNetInsiderBuy maxNetInsiderBuy Net buying by officers and directors
P/E minPe maxPe Trailing P/E
Dividend yield minDividendYield maxDividendYield Percent
Revenue growth minRevenueGrowth maxRevenueGrowth Percent, latest quarter YoY
Gross margin minGrossMargin maxGrossMargin Percent
Dollar volume minDollarVolume maxDollarVolume Trailing 3-month average daily dollar volume
Net income minNetIncome maxNetIncome Trailing twelve months

Other filters:

  • sector, industry, and hasGoingConcernDoubt restrict the matching companies.
  • index keeps members of one covered index, by slug or name: sp-500, S&P 500, nasdaq-100, or Russell 2000. An unknown name returns the accepted list.
  • market accepts comma-separated ISO country codes, such as GB,FR or CN,HK, or all. The default is US; an uncovered code returns the covered list.
  • tickers accepts up to 200 US symbols to screen stocks you already hold. Every other bound still applies. BRK.B resolves to the listed form, a secondary listing resolves to its issuer, and symbols outside the covered universe are named in the response.

A company listed in the US and on its home exchange, such as Shell, appears under its home listing when market names that country but not US.

Non-US rows carry identity, price and market cap only. Their ticker is a qualified MIC:TICKER symbol such as XPAR:AIR, which AddPortfolioLot, WatchInstrument and UnwatchInstrument accept and the other tools do not. Price and market cap are in USD at the official exchange rate, with the traded close beside the price.

Sorting and pagination:

  • sortBy: marketcap (default), ticker, name, price, filers, filerdelta, sipct, dtc, squeeze, sentiment, insiderbuy, pe, divyield, revgrowth, grossmargin, dollarvol, or netincome. Unknown keys are rejected.
  • sortAscending controls sort direction.
  • maxResults defaults to 50 and is clamped to 1–200.
  • page defaults to 1.

Ask: "Screen for $1B+ stocks with a squeeze score above 75."

Returns (trimmed):

# Stock screener — 307 match(es), showing rows 1-3

| Ticker | Company | Sector | Industry | Market | Market Cap | Price | 13F Filers | Δ Filers (QoQ) | SI % | Days to Cover | Squeeze | Insider Sentiment | Net Insider Buy (90d) | GC Doubt |
|---|---|---|---|---|---:|---:|---:|---:|---:|---:|---:|---:|---:|---|
| SNOW | Snowflake Inc. | Technology | Software - Application | US | $93,100,000,000 | $210.45 | 1,234 | +20 | 6.65% | 2.94 | 76 | 42 | $-470,300,000 | — |
| TRV | Travelers Cos. | Financial Services | Insurance - Property & Casualty | US | $72,600,000,000 | $281.30 | 1,101 | -4 | 3.74% | 2.86 | 75 | 38 | $-12,800,000 | — |
| NBIS | Nebius Group N.V. | Technology | Information Technology Services | US | $55,800,000,000 | $89.10 | 422 | +33 | 27.68% | 3.46 | 85 | 51 | $-141,100,000 | — |

GetGovernmentContracts

Federal contract awards won by a company, from USAspending — each with the award date, the recipient as the government named it, awarding agency, award type, total value, period-of-performance end, award ID, and description.

Read the Recipient column: an award frequently lands on a subsidiary's own name rather than the parent's, and that name is the evidence tying the award to this company. An Outlays column — what the government has actually disbursed against the award, as opposed to what it obligated — appears when the answer carries the figure; USAspending reports it on a minority of awards, so it is omitted rather than filling the table with dashes.

Parameters: ticker (required), startDate, endDate, maxResults, offset (default 0), sortBy (amount default — largest total value first — or date for most recent first), agency (case-insensitive substring on the awarding agency, e.g. Defense).

Ask: "What federal contracts has Lockheed Martin won recently?"

Returns (trimmed):

Federal contract awards for LMT (Lockheed Martin Corp), 2025-08-10 to 2026-08-10 — 2 awards totaling $5,967,553,394:

| Award Date | Recipient | Agency | Type | Total Value (obligated + ceiling) | Period End | Award ID | Description |
|------------|-----------|--------|------|-----------------------------------|------------|----------|-------------|
| 2026-04-09 | LOCKHEED MARTIN CORPORATION | Department of Defense | Definitive Contract | $4,761,000,000 | 2030-08-31 | W31P4Q26C0013 | EXECUTE PHASED ARRAY TRACKING RADAR TO I… |
| 2025-09-12 | LOCKHEED MARTIN CORPORATION | Department of Defense | Definitive Contract | $1,206,553,394 | 2030-09-30 | N0003025C0100 | FY26 TRIDENT PRODUCTION AND DEPLOYED SYS… |

GetTopGovernmentContractors

The companies that have won the most federal contract dollars over a window, ranked by total awarded, with the award count. Useful for sizing defense- and services-exposure across names.

Parameters: startDate, endDate, maxResults.

Ask: "Which public companies won the most federal contracts this year?"

Returns:

Top federal contractors (2025-07-14 to 2026-07-14):

| Rank | Ticker | Company              | Total Value (obligated + ceiling) | Awards |
|------|--------|----------------------|-----------------------------------|--------|
| 1    | LMT    | Lockheed Martin Corp | $188,834,883                      | 2      |

GetFdaAdvisoryCommitteeMeetings

Scheduled FDA advisory-committee meetings, soonest first, with the date, meeting title, FDA center, type, and a link to the per-meeting FDA page (the only place that names the product and sponsor under review). A forward-looking list of announced meetings, not a historical archive (coverage starts in late 2025), and entries are not linked to stock tickers. Malformed or inverted date arguments return an error instead of silently searching a different window, and an empty window reports the calendar's covered span.

Parameters: startDate, endDate (YYYY-MM-DD), maxResults.

Ask: "What FDA advisory meetings are coming up?"

Returns (trimmed):

FDA Catalyst Calendar (advisory-committee meetings, 2026-07-17 to 2026-10-15):

| Date       | Meeting                                            | Center | Type                       | Details                    |
|------------|----------------------------------------------------|--------|----------------------------|----------------------------|
| 2026-07-23 | Pharmacy Compounding Advisory Committee            | CDER   | Advisory Committee Meeting | https://www.fda.gov/…      |
| 2026-07-29 | Cellular, Tissue, and Gene Therapies Adv. Committee| CBER   | Advisory Committee Meeting | https://www.fda.gov/…      |